Target intelligence / Profile preview

Plasma and serum protein

Molecular classification
Other
01

Overview

Plasma and serum protein refers to the heterogeneous collection of proteins found in the liquid portion of blood, including albumin, globulins, and fibrinogen (StatPearls, 2023). These proteins perform essential physiological roles such as maintaining colloid osmotic pressure, buffering blood pH, and transporting lipids, hormones, and vitamins throughout the body (Wikipedia, 2024). While the category itself is not a single therapeutic target, it is of paramount importance in pharmacology because the majority of drugs bind to these proteins, particularly albumin and alpha-1-acid glycoprotein (PubMed, 2021). This binding determines the "free fraction" of a drug, which is the pharmacologically active portion capable of diffusing to target tissues (NIH, 2023). Pathological conditions like cirrhosis or nephrotic syndrome can significantly alter protein levels, leading to unpredictable drug responses or increased risk of toxicity due to displacement or reduced binding capacity (NCBI, 2023). Furthermore, specific proteins within this group, such as clotting factors or complement components, serve as specific targets for various hematological and immunological therapies (PubMed, 2020). Understanding these interactions is vital for predicting drug-drug interactions, especially for drugs with a narrow therapeutic index (NCBI, 2023).

Other names
Blood proteinsSerum proteinsPlasma proteomeCirculating proteins
02

Mechanism of action

Drugs interact with these proteins primarily through reversible, non-specific binding, which regulates the systemic distribution and the pharmacologically active free fraction of the drug in circulation.

03

Biological functions

TransportOsmotic pressure regulationImmune responseBlood coagulationpH bufferingEnzymatic activity
04

Disease associations

Liver diseaseKidney diseaseInflammationMalnutritionCoagulopathyAmyloidosis
05

Safety considerations

Drug-drug interactions via displacement from binding sitesIncreased drug toxicity in hypoalbuminemic statesAltered pharmacokinetics in renal or hepatic impairmentSaturation of binding capacity at high drug concentrations
06

Interacting drugs

Warfarin

7 more in the full profile.

07

Biomarkers

Serum albumin levelTotal serum proteinC-reactive protein (CRP)International Normalized Ratio (INR)PrealbuminAlpha-1-acid glycoprotein

Beyond the preview

Go deeper on Plasma and serum protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma and serum protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call